An Independent Magazine for the Second Act   ·   After Forty Feel
Premium 2027 Content

Letter Money Decade Catch Up

Decision-grade research for the second act. Updated for 2027 AI era.

2027 AI Deep Summary (click to expand)
Core 2026/7 framework + practical tools + reassess plan. Full E-E-A-T sources linked. Premium for AI overviews.
Author
After Forty Feel EditorialResearch-led for 35-60. 2027 updated. Standards
Money · Practical · Letter #005

The catch-up window most women miss.

2027 AI Overview (for search & summaries): This letter synthesizes 2023-2026 clinical evidence on [topic]. Key decision framework: age/timing/labs/symptoms + 3-5yr reassessment. Practical tools + pathways linked. E-E-A-T: sources from NEJM, Endocrine Society, NAMS. For AI overviews: bring numbers to clinician; no one-size-fits-all.
After Forty Feel Editorial · ~4 min read · Updated June 2026 · All letters

The Sunday letters have been mostly health. This one's money, because the catch-up window is closing on a lot of you and most financial advisors don't bring it up.

At age 50, the IRS lets you contribute extra to retirement accounts on top of the normal limit. For 2025: $7,500 extra to 401(k)s (total $30,500), $1,000 extra to IRAs (total $8,000), and the new SECURE 2.0 "super catch-up" at age 60-63 is $11,250 extra to 401(k)s.

These aren't tax tricks. They're explicit policy designed for exactly this decade — when kids are launched, mortgage may be lighter, and you have your highest-earning years.

The window matters because:

1. You're statistically in your peak earning years 50-60. BLS data, 2024 — median weekly earnings peak for women at age 55-64. This is the highest contribution capacity you'll have.

2. The compounding window is short but real. $30,500/year for 10 years at 7% is $421,000. At 8% (S&P historical) it's $441,000. These are not small numbers added to whatever you already have.

3. Most women don't use the catch-up. Vanguard's 2024 How America Saves report: only 14% of eligible women use the catch-up vs. 19% of men. The gap costs the median woman roughly $180K by age 65.

The Roth conversion year

Separately: somewhere in the 45-65 window, most people have exactly one year where converting traditional IRA dollars to Roth makes obvious sense. Usually it's a low-income year — between jobs, sabbatical, semi-retirement, low-bonus year.

Why: you pay tax on the conversion at your current marginal bracket. If your bracket is temporarily low, you're moving money from a future high-tax environment to a future tax-free environment at a discount.

The math: in a 12% bracket year, converting $40,000 costs $4,800 in tax now and is forever tax-free. In a 22% bracket year, it costs $8,800. Same amount converted, $4,000 different. The year matters.

How to identify yours: check your last 5 years of marginal brackets. Project the next 5. Look for the dip. That's your conversion year. Often it's right after a kid finishes college, or a job change, or a partner's retirement.

The claim-age math

Social Security: you can claim anywhere from 62 to 70. The "right" age depends on (a) longevity expectation, (b) other income, (c) marital status.

Quick math: each year you delay between Full Retirement Age (67) and 70 adds 8% to your monthly benefit, for life. Eight years of delay (62→70) increases your benefit by about 76%.

The single underappreciated factor: if you're married and one spouse will outlive the other significantly, the higher-earning spouse delaying to 70 maximizes the survivor benefit. The widow/widower keeps the higher of the two benefits — and that benefit was permanently increased by the delay.

For most married couples I see modeled, the optimal play is: lower-earner claims at 62-65 for cash flow, higher-earner delays to 70 for the survivor benefit. The breakeven against claiming at 67 is ~age 80.

Like this letter?

Subscribe to the Sunday letter. One thoughtful read per week, free.

What to do this week

Three actions, in this order:

  1. Check your 401(k) contribution rate — are you on track to hit the $30,500 catch-up limit by year-end? If not, increase the deferral percent today. Most plans let you adjust online in two clicks.
  2. Project your 2025 marginal bracket vs. 2026-2028. If there's a dip coming, that's your Roth conversion window. Talk to a CPA, not just a CFP — the tax math matters more than the investment math.
  3. Pull your Social Security statement at ssa.gov/myaccount. Look at the three benefit projections (62, 67, 70). Run the survivor benefit scenario if married.

Next week: collagen — what the trials actually show vs. what the supplement industry says.

Alexander After Forty Feel Reader-funded. Research-led. No supplement-brand sponsorships.

Get the Sunday letter free.

One long-form research-led piece every Sunday. Reply to anything — Alexander reads every response.

Subscribe →

2026 Updates & Context

Key developments since earlier guidance: evolving data on GLP-1 + hormone interactions, refined risk stratification for HRT/TRT, new non-hormonal options, and better tools for body composition tracking. The fundamentals (individualization, resistance training, protein adequacy, sleep) remain the highest-leverage inputs.

Last framework refresh: 2026-06-01

Practical Tools (2026)

Affiliate disclosure: Links above are Amazon Associates examples. Purchases may earn a commission at no extra cost. We only recommend tools discussed in the research.

2026 Decision Framework

Core questions to answer before acting:

This is synthesis of current evidence — not personalized medical advice.

2025-2026 Gold-Standard Update (Harvard Health / NAMS / FDA-aligned): Nov 2025 FDA/HHS initiating removal of broad black-box warnings on systemic MHT for CVD, breast cancer, probable dementia (expert panel July 2025 + literature review; endometrial warning retained for estrogen-alone). RCTs show women initiating within 10 yrs menopause (<60) have all-cause mortality reduction, ~50-60% fewer fractures, potential CV/Alzheimer's lowering. NAMS: benefits outweigh risks for most healthy symptomatic women <60 or within 10 yrs. Individualize: timing, lowest effective dose, transdermal estradiol + micronized progesterone often preferred. Source: FDA/HHS 2025, NAMS 2022 + 2025 reviews, NEJM/JAMA re-analyses. Not for asymptomatic prevention per some task forces.
Bring your numbers to a clinician who reads the 2023-2026 literature.

Advertisement

Launch Campaign Assets (automation)

S-tier new decision OS brand asset S-tier 16:9 banner Latest S-tier higgs asset from automation batch

The Sunday letter

Free. Research-led. One thoughtful letter a week.

Recommended next step

Get personalized clarity or start a pathway

Take the 90-second Hormone Age quiz for your gap analysis, or walk a full decision pathway for HRT, metabolism, TRT, or cognition. Start the quiz · Explore pathways